Please check back on the 1st of the month to view the Halozyme Therapeutics, Inc. Annual Reports. In the meantime, here are a few annual reports from similar companies.
Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. The company's product portfolio is primarily based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix.
Search by company name or ticker symbol